Astellas Pharma US, Inc has chosen Illinois for its new headquarters for the Americas. Construction of the new headquarters is scheduled to be completed in the spring of 2012.
Illinois Governor Pat Quinn, who attended the company’s groundbreaking ceremony, announced an approximately $4 million investment package to assist Astellas Pharma in establishing its new corporate headquarters in Glenview.
The development will result in strengthening of the economy of Northeast Illinois and new pharmaceutical jobs. The state’s business package will leverage $140 million in private investment and will create 150 new jobs.
The company’s current Deerfield-based employees will be relocating to the new headquarters. The new headquarters will include two six-story buildings totaling 425,000 square feet.
The state’s investment package, administered by the Department of Commerce and Economic Opportunity (DCEO), will consist of Economic Development for a Growing Economy (EDGE) corporate income tax credits, which are based on job creation, and Employer Training Investment Program (ETIP) job training funds that will help enhance the skills of its workforce.
Astellas’ expansion will also support Illinois’ growing life sciences industry. Illinois’ biopharmaceutical industry, which is supported by the state’s highly-regarded federal labs and top-notch research universities, directly employs more than 40,000 people and supports more than 112,000 indirect and induced jobs.
Astellas Pharma US, Inc., is the U.S. affiliate of Astellas Pharma Inc., Japan’s second largest pharmaceutical company. In 2008, Astellas established the Astellas’ Global Pharma Development headquarters in Deerfield, moving them from Japan. The group has approximately 15,000 employees worldwide.
Related posts: